1. A. N. Boiko and E. I. Gusev, “Current approaches to the treatment of multiple sclerosis,” Neurol. Vestn. V. M. Bekhtereva, XLII, No. 1, 156–157 (2010).
2. A. N. Boiko, I. D. Stolyarov, A. M. Petrov, et al., “Potential new methods for the pathogenetic treatment of multiple sclerosis,” ibid., 157–159.
3. A. M. Petrov and I. D. Stolyarov, “Some aspects of current immunodiagnosis and immunotherapy of multiple sclerosis,” in: Proc. 10th All-Russ. Congr. Neurologists with Int. Participation [in Russian], Nizhnii Novgorod (2012), p. 235.
4. E. V. Popov, M. V. Davydovskaya,V. V. Ovcharov, et al., “Experience in the use of natalizumab at the Moscow City Multiple Sclerosis Center,” ibid., p. 237.
5. T. E. Shmidt and N. N. Yakhno, Multiple Sclerosis: Handbook for Physicians [in Russian] (2010), 2nd ed., pp. 200–202.